|
Recent Developments |
|
24-DEC-18
Unichem Laboratories has received final ANDA approval for its Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg and 1.5 mg
12-DEC-18
Unichem Laboratories has received tentative approval for its ANDA, Tadalafil Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg from the USFDA for a generic version of Eli Lilly's Cialis, 2.5 mg, 5 mg, 10 mg and 20 mg.
04-JUL-18
Unichem Laboratories has received final ANDA approval for... More.. |
| Business Profile |
Future Plans |
|
| CEO Talk | | `I am yet to come across a brand sale where the buyer has benefited`, says he, being very cautious on acquisition plans. Dr Prakash A Mody |
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2019(9) | 31-Mar-2019 (12) | 31-Mar-2018(12) | | Net sales | 6888.13 | 9677.39 | 9015.60 | | Other Income | 800.42 | 1015.42 | 671.89 | | Total Income | 7688.55 | 10692.81 | 9687.49 | | Cost of goods sold | -8211.22 | -10908.61 | 8982.22 | | OPBDIT | 15899.77 | 21601.42 | 705.27 | | PAT | -447.69 | 87.99 | -84.00 | | Gross Block | - | - | - | | Equity capital | - | 0.00 | 140.67 | | EPS (Rs.) | - | 0.00 | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | NA | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 206.8 | 202.0 | 7.3 | | Net margin (% of OI) | -5.8 | 0.8 | -0.9 |
|
|
Detailed Financials
|
|
|
|
|
